Article

Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells

2022-08-27

Abstract excerpt

Cytotoxic CD8+ T lymphocytes (CTLs) are key players of adaptive anti-tumor immunity based on their ability to specifically recognize and destroy tumor cells. Many cancer immunotherapies rely on unleashing CTL function. However, tumors can evade killing through strategies which are not yet fully elucidated. To provide deeper insight into tumor evasion mechanisms in an antigen-dependent manner, we established a huma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 25eb3635-4dde-58f6-b7e9-fc9df3a09923
DOI: 10.1101/2022.08.26.505456

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cellsDOI 10.1101/2022.08.26.505456Read

Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cellsSemantic proximity Read

Natural Killer Cells Suppress T Cell-Associated Tumor Immune EvasionSemantic proximity Read

CRISPR/Cas9 edited tumor-associated immune cells in cancer immunotherapySemantic proximity Read

Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killingSemantic proximity Read

Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapySemantic proximity Read

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapySemantic proximity Read

Multi-modal pooled Perturb-CITE-Seq screens in patient models define novel mechanisms of cancer immune evasionSemantic proximity Read

Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulatorsSemantic proximity Read

Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapySemantic proximity Read

CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applicationsSemantic proximity Read

Rational design of immune gene therapy combinations via <i>in vivo</i> CRISPR activation screen of tumor microenvironment modulatorsSemantic proximity Read

Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screeningSemantic proximity Read